chevron_left
Exploring Strategic Agility in Medtech Through Innovation, Divestitures, and Global Expansion
Speakers
Medtech Trends to Watch 2025
As the medtech industry undergoes a transformative era marked by rapid technological advances and evolving regulatory landscapes, companies face the challenge of balancing innovation with financial sustainability. Portfolio rebalancing through acquisition of niche innovators, divestiture of mature segments, and iterative enhancements of existing technologies is emerging as a critical strategy.
In this interview, Mike Ward speaks with Juliane Ray from Clarivate about how leading medtech firms are prioritizing high-growth therapeutic areas, leveraging differentiated technologies, and adapting to global market complexities to remain competitive.
This video will answer questions such as:
- What criteria guide decisions to acquire niche innovators or divest mature product lines?
- How do companies weigh growth potential against short-term revenue impact?
- What role do iterative improvements in mature markets play in sustaining profitability?
- How are medtech leaders adjusting portfolios to capitalize on emerging markets while navigating local regulatory demands?
- What KPIs and strategic considerations are essential for successful portfolio rebalancing?
